Bill Few Associates Inc. Sells 500 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Bill Few Associates Inc. trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,905 shares of the biopharmaceutical company’s stock after selling 500 shares during the quarter. Bill Few Associates Inc.’s holdings […]

Related Keywords

United States ,Complera Eviplera ,Merdad Parsey ,Andrewd Dickinson ,Nasdaq ,Investment Advisory Services Inc ,Barclays ,Gilead Sciences Increases Dividend ,Gilead Sciences Price Performance ,Quarter For Gilead Sciences ,Exchange Commission ,Tompkins Financial Corp ,Gilead Sciences Inc ,Few Associates Inc ,Union Savings Bank ,Fortitude Family Office ,Gilead Sciences ,News Ratings For Gilead Sciences Daily ,Securities Exchange Commission ,Bill Few Associates ,Free Report ,Few Associates ,Advisory Services ,Asset Management ,Financial Corp ,Savings Bank ,Get Free Report ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,